SNDX   $18.64  3.56% Market Closed After Close 18.63 -0.05%

Syndax Pharmaceuticals Inc
Total Cash 432.27M
totalCashPerShare 5.08
EBITDA -287.98M
Total Debt 1.13M
quickRatio 10.434
currentRatio 10.502
Total Revenue 3.50M
debtToEquity 0.26
Revenue/Share 0.045
ROA -0.39633998
ROE -0.633
grossProfits
freeCashflow -143.14M
operatingCashflow -241.20M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -21.20457
profitMargins 0.0
enterpriseValue 1.20B
forwardPE -5.9195046
floatShares 84.76M
sharesOutstanding 85.10M
sharesShort 9.49M
sharesShortPriorMonth 8.59M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.06%
Short Ratio help_outline 10.99%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 5.108
Price To Book help_outline 3.74
earningsQuarterlyGrowth
netIncomeToCommon -264.08M
trailingEps -3.40%
forwardEps -3.23%
enterpriseToEbitda -4.15
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.11 3Q 2024
institutionsCount 276
lastUpdated Sept. 16, 2024, noon